Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

Since entering the allergy field, Priya J. Bansal, MD, FAAAAI, FACAAI, has seen positive changes, including the entry of more ...

The National Kidney Foundation published a consensus document that advocates transition to race-free eGFR equations in health ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

According to published results, patients with dysplasia with a trochlear bump and patella alta may be at increased risk for ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Results published in the American Journal of Sports Medicine showed surgical delays of more than 4 months may increase the ...